Abstract
In most retinal diseases, neuronal loss is the main cause of vision loss. Neuroprotection is the alteration of neurons and/or their environment to encourage the survival and function of the neurons, especially in environments that are deleterious to the neuronal health. The area of neuroprotection progresses with a therapeutically-based hope of improving vision and clinical outcomes for patients through the developments in neurotrophic therapy, antioxidative therapy, anti-excitotoxic, anti-ischemic, anti-inflammatory, and anti-apoptotic care. In this review, we summarize the various neuroprotection strategies for the treatment of glaucoma, genetics of glaucoma and the role of various nanoplatforms in the treatment of glaucoma.
| Original language | English |
|---|---|
| Article number | 173208 |
| Journal | European Journal of Pharmacology |
| Volume | 881 |
| DOIs | |
| Publication status | Published - 15-08-2020 |
All Science Journal Classification (ASJC) codes
- Pharmacology
Fingerprint
Dive into the research topics of 'Neuroprotection: A versatile approach to combat glaucoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver